From the Journals

The psychopathic brain: New insight


 

Larger studies needed

Commenting on the findings for this news organization, Terrie E. Moffitt, PhD, professor of psychology, Duke University, Durham, N.C., noted that there is “general consensus among brain-imaging researchers that testing brain-behavior relations requires very large samples in the thousands and also samples of research participants who represent the full extent of variation in the population as well as possible – from rich to poor, from well to unwell, from high IQ to low IQ, from strong mental health to mental illness, etc.

“It would be grand to see this study’s provocative finding replicated in a large, representative sampling design,” Dr. Moffitt said.

The study was supported in part by the National Institutes of Health. Dr. Choy, Dr. Raine, and Dr. Moffitt have disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Mental illness tied to COVID-19 breakthrough infection
MDedge Psychiatry
New combination med for severe mental illness tied to less weight gain
MDedge Psychiatry
High antipsychotic switch rates suggest ‘suboptimal’ prescribing for first-episode psychosis
MDedge Psychiatry
Virtual reality therapy promising for agoraphobia
MDedge Psychiatry
Cats, toxoplasmosis, and psychosis: Understanding the risks
MDedge Psychiatry
Higher ‘chemical restraint’ rates in Black psych patients in the ED
MDedge Psychiatry
Do psychotropic meds raise or lower COVID risk in psych patients?
MDedge Psychiatry
New data support electroconvulsive therapy for severe depression
MDedge Psychiatry
Clozapine and cancer risk in schizophrenia patients: New data
MDedge Psychiatry
Neuropsychiatric risks of COVID-19: New data
MDedge Psychiatry